Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Genetic Investigation of the Role of GDF11 in the Treatment of β-Thalassemia and MDS

Paraskevi Rea Oikonomidou, MD, Ping La, PhD, Ritama Gupta, MSc, Vania Lo Presti, Carla Casu, PhD, Laura Breda, PhD, Deborah Watson, PhD, Rajasekhar NVS Suragani, PhD, Ravindra Kumar, PhD, Stefano Rivella, PhD

Blood (2016) 128 (22): 2439.

https://doi.org/10.1182/blood.V128.22.2439.2439

Published: 2016

Journal Articles

Rap-536 (Murine ACE-536/Luspatercept) Inhibits Smad2/3 Signaling and Promotes Erythroid Differentiation By Restoring GATA-1 Function in Murine b-Thalassemia

Pedro A. Martinez, PhD, Rajasekhar NVS Suragani, PhD, Manoj Bhasin, PhD, Robert Li, Robert Scott Pearsall, PhD, Ravindra Kumar, PhD

Blood (2015) 126 (23): 751.

https://doi.org/10.1182/blood.V126.23.751.751

Published: 2015

Journal Articles

TGFb1 Antagonist Inhibits Fibrosis in a Murine Model of Myelofibrosis

Rajasekhar NVS Suragani, PhD, Pedro A. Martinez, PhD, Sharon M Cawley, PhD, Robert Li, Robert Scott Pearsall, PhD, Ravindra Kumar, PhD

Blood (2015) 126 (23): 605.

https://doi.org/10.1182/blood.V126.23.605.605

Published: 2015

Journal Articles

Modified Actriib-Fc Fusion Protein (ACE-536) Mitigates Sickling and Red Cell Pathology in a Murine Model of Sickle Cell Disease

Rajasekhar NVS Suragani, PhD, Robert Li, Sharon M Cawley, R. Scott Pearsall, Ravindra Kumar

Blood (2014) 124 (21): 4055.

https://doi.org/10.1182/blood.V124.21.4055.4055

Published: 2014

Journal Articles

Modified Activin Receptor Type IIb-Fc Fusion Protein (RAP-536) Decreases Anemia In a Murine Model Of Myelodysplastic Syndrome and Improves Overall Survival

Rajasekhar NVS Suragani, PhD, Robert Li, Sharon Cawley, R. Scott Pearsall, Ph.D., Ravi Kumar, Ph.D.

Blood (2013) 122 (21): 749.

https://doi.org/10.1182/blood.V122.21.749.749

Published: 2013

NARROW

Genetic Investigation of the Role of GDF11 in the Treatment of β-Thalassemia and MDS

Rap-536 (Murine ACE-536/Luspatercept) Inhibits Smad2/3 Signaling and Promotes Erythroid Differentiation By Restoring GATA-1 Function in Murine b-Thalassemia

TGFb1 Antagonist Inhibits Fibrosis in a Murine Model of Myelofibrosis

Modified Actriib-Fc Fusion Protein (ACE-536) Mitigates Sickling and Red Cell Pathology in a Murine Model of Sickle Cell Disease

Modified Activin Receptor Type IIb-Fc Fusion Protein (RAP-536) Decreases Anemia In a Murine Model Of Myelodysplastic Syndrome and Improves Overall Survival

Email alerts

ASH Publications

American Society of Hematology

Genetic Investigation of the Role of GDF11 in the Treatment of β-Thalassemia and MDS

Rap-536 (Murine ACE-536/Luspatercept) Inhibits Smad2/3 Signaling and Promotes Erythroid Differentiation By Restoring GATA-1 Function in Murine b-Thalassemia

TGFb1 Antagonist Inhibits Fibrosis in a Murine Model of Myelofibrosis

Modified Actriib-Fc Fusion Protein (ACE-536) Mitigates Sickling and Red Cell Pathology in a Murine Model of Sickle Cell Disease

Modified Activin Receptor Type IIb-Fc Fusion Protein (RAP-536) Decreases Anemia In a Murine Model Of Myelodysplastic Syndrome and Improves Overall Survival

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only